Gator Bio is a pre-IPO biotech company located in Palo Alto, CA. We are creating innovative technologies to solve difficult problems facing today’s healthcare industries. We develop, manufacture and market instruments, biosensors, reagents, and consumables for in-vitro diagnostics and biotherapeutic development. Our mission is to simplify and accelerate biological analysis for biotherapeutic research and development.
We are searching for aSenior Bioconjugation Chemist to join our Research & Development team. This scientist will be responsible for developing bioanalytical products based on both solid phase and liquid phase chemistry. This position will be involved in research and development from feasibility to launch.
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
Gator Bio, a pioneering pre-IPO biotech firm located in the heart of Palo Alto, CA, is on a mission to tackle some of the most complex issues in the healthcare sector. We're excited to announce that we're looking for a Senior Bioconjugation Chemist to join our dynamic Research & Development team. In this role, you'll be at the forefront of innovation, developing bioanalytical products that play a critical role in in-vitro diagnostics and biotherapeutics. Your responsibilities will include driving bioconjugation projects for cutting-edge assays and engaging closely with our assay development team to create reagents that will pave the way for future breakthroughs. With a focus on both solid phase and liquid phase chemistry, you're not just a scientist; you're a problem-solver contributing to exciting projects from feasibility all the way to product launch. Collaboration is key, as you'll support the transfer of protocols to manufacturing and explore new strategies in bioconjugation. If you are passionate about chemistry and eager to make a tangible impact in healthcare, come join us at Gator Bio where your expertise will help shape the future of biotherapeutic research and development!
Subscribe to Rise newsletter